Skip to content Skip to navigation

McKesson talks top trends for 2015

December 11, 2014
by Julia Brown
| Reprints

Big data and 340B, a discount drug program, were identified as top trends that will impact the healthcare system in 2015, according to the McKesson Pharmacy Optimization team, a group of advisors partnering with health system pharmacies.

With a continued focus on program integrity and compliance with government regulations, there is a need for 340B covered entities to ensure compliance for split-billing and contract pharmacy scenarios, says McKesson. A complex program, 340B offers eligible safety-net care providers access to manufacturer-discounted medications, which allows them to provide more care to vulnerable patient populations. It requires cooperation among health system departments to meet compliance requirements.

McKesson advised that even well-established 340B health systems should undergo a “best practices” assessment. Systems operating 340B programs need to ensure they are continually prepared for audits by using internal compliance programs and technologies.

Big data in patient safety, the continuum of care, payment models and reimbursement rates will also continue to play an increasingly important role in the year ahead. While data exists, the challenge is linking everything together and getting stakeholders to communicate. As health systems take on higher levels of financial risk, they can rely on a comprehensive analytics platform to track and monitor patient cost and quality, says McKesson.

Topics